Transdigm Q1 2024 Earnings Report
Key Takeaways
TransDigm Group Incorporated reported strong first-quarter results for fiscal year 2024, with net sales up 28% to $1,789 million and a 67% increase in net income to $382 million. Adjusted earnings per share rose by 56% to $7.16. The company has raised its full-year net sales and EBITDA As Defined guidance, reflecting the strong first-quarter performance and current expectations for the rest of the fiscal year.
Net sales increased by 28% to $1,789 million compared to the prior year's quarter.
Net income rose by 67% to $382 million from the previous year's quarter.
Adjusted earnings per share grew by 56% to $7.16 compared to $4.58 in the prior year's quarter.
Fiscal 2024 net sales and EBITDA As Defined guidance were revised upward.
Transdigm
Transdigm
Forward Guidance
TransDigm has raised its full year net sales and EBITDA As Defined guidance primarily to reflect strong first quarter results and current expectations for the remainder of the fiscal year.
Positive Outlook
- Net sales are anticipated to be in the range of $7,575 million to $7,755 million compared with $6,585 million in fiscal 2023.
- Net income is anticipated to be in the range of $1,560 million to $1,662 million compared with $1,299 million in fiscal 2023.
- Earnings per share is expected to be in the range of $25.25 to $27.01 per share based upon weighted average shares outstanding of 57.8 million shares, compared with $22.03 per share in fiscal 2023.
- EBITDA As Defined is anticipated to be in the range of $3,920 million to $4,050 million compared with $3,395 million in fiscal 2023, corresponding to an EBITDA As Defined margin guide of approximately 52.0% for fiscal 2024.
- Adjusted earnings per share is expected to be in the range of $29.97 to $31.73 per share compared with $25.84 per share in fiscal 2023.
Challenges Ahead
- The impact of this guidance raise will be partially offset by the additional interest expense relating to the financing activities completed during the quarter.
- Incremental debt was taken on to fund the pending acquisition of CPI's Electron Device Business.
- This guidance excludes any EBITDA As Defined contribution from the pending acquisition of CPI's Electron Device Business.
- Commercial OEM revenue growth around 20%.
- Commercial aftermarket revenue growth in the mid-teens percentage range.